August 3, 2026 · Form 4 insider transaction
Parschauer Karah Herdman sold 1,900 shares of Ultragenyx Pharmaceutical Inc. at $24.92 per share, a transaction worth $47.3K. The trade was recorded as open-market sale and disclosed on an SEC Form 4, filed 1 day after the transaction.
Includes previously reported shares of common stock underlying RSUs granted to the Reporting Person, which are subject to certain vesting conditions.